Revisiting the Heterogeneous IFN-γ Response of Bacille of Calmette-Guérin (BCG)-Revaccinated Healthy Volunteers in a Randomized Controlled Trial: Effect of the Body Mass Index and of the IFNG+874 A/T Polymorphism.

Elisabete L Conceição, Francisco S Nascimento-Sampaio, Paulo A Schwingel, Evelin S Oliveira, Michael S Rocha, Igor Vieira, Carlos M C Mendes, Adelmir Souza-Machado, Martha M Oliveira, Manoel Barral-Netto, Jamocyr M Marinho, Theolis Barbosa

Journal: PloS one 2017;11(7):e0160149

PMID: 27472280

Abstract

In trials evaluating the immune responses to Bacille of Calmette-Guérin (BCG), the genetic background and the nutritional status are host-related factors that could affect the heterogeneity in these parameters. The IFNG+874 A/T (rs 62559044) polymorphism has been reported to influence the IFN-γ production by BCG-vaccinated individuals challenged in vitro with mycobacterial antigens. The body mass index (BMI) is a proxy for the nutritional status and has been associated both with the susceptibility to tuberculosis and with the IFN-γ response. We show that although the IFNG+874 A/T polymorphism was not associated with the heterogeneity of IFN-γ production in a randomized controlled trial that evaluated long-term immune responses to BCG revaccination previously conducted in Salvador, Bahia, Brazil, the effect of this polymorphism on the observed increase in IFN-γ production among revaccinated subjects was adjusted in individuals with a low BMI.

Address: Universidade Federal da Bahia, Salvador, BA, Brazil.; Instituto Gonçalo Moniz, Fundação Oswaldo Cruz, Salvador, BA, Brazil.; Escola Bahiana de Medicina e Saúde Pública, Salvador, BA, Brazil.; Faculdade de Medicina, Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ, Brazil.; Hospital Santa Izabel, Salvador, BA, Brazil.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.